
pmid: 28609660
Immunotherapy has changed the landscape of cancer treatment. Checkpoint blockade therapies unleash breaks in the immune system and induce long-lasting responses. However, a significant number of patients do not respond (innate resistance), and a subset progress after responding (acquired resistance). A better understanding of the molecular mechanisms underlying checkpoint blockade therapies will facilitate the design of novel strategies to treat and prevent resistance. To view this SnapShot, open or download the PDF.
Prevention, Oncology and Carcinogenesis, Drug Resistance, Neurosciences, Cell Cycle Checkpoints, Adaptive Immunity, Vaccine Related, Good Health and Well Being, Clinical Research, 5.1 Pharmaceuticals, Drug Resistance, Neoplasm, Neoplasms, Neoplasm, Humans, Immunization, Oncology & Carcinogenesis, Immunotherapy, Interferons, Development of treatments and therapeutic interventions, Cancer
Prevention, Oncology and Carcinogenesis, Drug Resistance, Neurosciences, Cell Cycle Checkpoints, Adaptive Immunity, Vaccine Related, Good Health and Well Being, Clinical Research, 5.1 Pharmaceuticals, Drug Resistance, Neoplasm, Neoplasms, Neoplasm, Humans, Immunization, Oncology & Carcinogenesis, Immunotherapy, Interferons, Development of treatments and therapeutic interventions, Cancer
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 266 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
